Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular Toradol vs Oral Ibuprofen for Osteoarthritis Knee Pain
NCT02966288Phase 4Withdrawn
- Sponsor
- UTHealth Houston
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of ketorolac in osteoarthritis (OA), sponsored by UTHealth Houston. Primary endpoints: Pain Medication Usage for Breakthrough Pain at 72 hours and Visual Analogue Scale at 72 hours. Planned start Jan 2017; status: withdrawn.
02
Drugs
ketorolac
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02966288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02966288.